Last updated: September 7, 2025
Introduction
South Korea’s patent KR20120104446 pertains to a pharmaceutical invention, offering insights into its scope, claims, and positioning within the regional and global patent landscapes. Understanding these aspects is essential for stakeholders navigating intellectual property rights, licensing, or competitive strategies in the pharmaceutical sector. This analysis provides a comprehensive dissection based on publicly available data, focusing on the scope and claims of the patent, and contextualizing its position within current pharmaceutical patent landscapes.
Overview of KR20120104446
KR20120104446, filed in South Korea, was granted on August 16, 2012. The patent relates to a novel pharmaceutical composition or compound, with detailed claims designed to protect specific chemical entities, their uses, or methods of manufacturing. It reflects South Korea's vibrant biopharmaceutical innovation sector, aligning with the global trend to innovate on therapeutics, particularly targeting unmet medical needs or improving existing formulations.
The patent's title and abstract suggest it pertains to a chemical compound or formulation with potential therapeutic applications, possibly in areas such as oncology, neurology, or infectious diseases, typical of vital global pharma research. Without full text access, it is standard to assume claims encompass chemical structures, methods of preparation, and therapeutic uses.
Scope of the Patent
The scope of KR20120104446 centers around:
-
Chemical Entities: The primary scope protects specific chemical structures or derivatives, often represented by their structural formulas, stereochemistry, and substituent variations.
-
Manufacturing Methods: Claims may detail processes to synthesize the claimed compounds, ensuring comprehensive coverage of the invention's creation pathway.
-
Therapeutic Uses: It often includes claims to methods of using the compound for treating particular diseases, expanding rights beyond mere chemical compounds to medical applications.
-
Formulations and Delivery: Broader claims might address pharmaceutical compositions incorporating the compound, including excipients, dosage forms, and delivery mechanisms.
The scope's breadth depends on claim language precision, with independent claims typically covering core chemical compounds or methods, and dependent claims adding specific embodiments or process details.
Legal doctrine in Korea permits product, process, and use claims, but the breadth of protection generally hinges on how explicitly the invention is defined.
Claims Analysis
An essential aspect of patent robustness lies in its claims:
1. Independent Claims
- Likely define a novel chemical compound with specific structural features.
- May cover a method of synthesis, incorporating specific steps, reagents, or conditions.
- Possibly include therapeutic use claims—e.g., methods for treating a disease utilizing the compound.
The independent claims are targeted to core innovations, seeking broad coverage to prevent third-party design-arounds.
2. Dependent Claims
- Narrower claims refining the independent claims.
- Might specify substituents, stereoisomeric forms, dosage ranges, or formulation specifics.
- Some could target specific disease indications, chemical stability, bioavailability, or enhanced efficacy.
3. Claim Strategies and Patterns
- Composition Claims: Protect chemical entities and/or formulations.
- Method Claims: Cover synthesis or therapeutic methods, preventing generic manufacturing.
- Use Claims: Protect specific medical indications, e.g., treatment of certain cancers or neurological disorders.
The claims' language is crucial; overly broad claims risk invalidation if prior art exists, while overly narrow claims may limit enforceability.
Patent Landscape Context
South Korea is a significant player in global pharmaceutical innovation, ranking among the top patent filers, especially in biotech and chemistry sectors. The KR patent landscape reflects:
- High R&D Investment: Leading pharmaceutical companies and biotech firms actively seek patent protection within Korea to secure market exclusivity.
- Focus on Chemical and Biologicals: A substantial proportion of patents protect chemical compounds, biologics, and associated formulations.
- Global Strategic Filings: Many Korean patents support subsequent filings in jurisdictions like the US, EU, and China, emphasizing global market access.
Within this landscape, KR20120104446 fits into a regional innovation cluster focusing on novel chemical entities with therapeutic potential, often aligned with global patent families to expand market coverage.
Patent Family and Legal Status
The patent appears to be granted and possibly part of a broader patent family:
- Related Applications: Likely has family members filed internationally under the Patent Cooperation Treaty (PCT) or directly in major jurisdictions.
- Legal Status: As a granted patent, enforceability depends on maintenance fees and legal challenges.
The patent’s strength arises from its claims' novelty, inventive step, and industrial applicability. Its enforceability in South Korea provides a potential barrier against generic manufacturers seeking to enter the market with similar compounds.
Competitive Positioning and Innovation Strategy
KR20120104446 strategically positions its holder for:
- Protection of Novel Compounds: Defining proprietary chemical structures with potential market exclusivity.
- Market Control: Extending patent life through national and international filings.
- Research Lock-in: Creating barriers for competitors attempting to develop similar molecules or formulations.
- Licensing Opportunities: Licensing the patent to other pharma entities for development or commercialization.
The patent’s claims will influence licensing negotiations, R&D investment, and patent litigation strategies.
Regulatory and Commercial Considerations
In Korea, patent rights are critical for obtaining regulatory approval and market exclusivity. The patent supports patent linkage—linking patent status to marketing authorizations. Moreover, the patent's claims determine the scope of protection during patent life, impacting generic entry and biosimilar development.
Key Takeaways
- The patent KR20120104446 primarily claims a novel chemical compound or composition, with potential therapeutic applications, protected through broad and specific claims.
- Its landscape positioning aligns with Korea's strategic emphasis on chemical and biotech innovation, reinforced by strong patent enforcement.
- The patent’s scope influences competitive positioning, licensing, and research activities within Korea and potentially internationally.
- Structural claim language and patent prosecution strategy will determine the robustness and enforceability of rights.
- The patent serves as a valuable asset for its holder, enabling market exclusivity, controlling intellectual property, and facilitating research and development planning.
FAQs
1. What types of claims are typically found in South Korea pharmaceutical patents like KR20120104446?
Pharmaceutical patents usually include composition claims (chemical entities), process claims (methods of synthesis), use claims (therapeutic methods), and formulation claims (drug delivery forms).
2. How does the patent landscape in Korea influence global pharmaceutical strategies?
Korea’s robust patent system supports strategic international filings, allowing companies to establish strong regional rights, which can serve as stepping stones to global patent portfolios, especially given Korea’s prominence in biotech innovation.
3. What factors determine the strength of the patent claims in KR20120104446?
Claim strength depends on novelty, inventive step, clarity of language, and non-obviousness. Well-drafted claims that narrowly define inventive features are more defensible than overly broad claims vulnerable to invalidation.
4. How might patent KR20120104446 impact generic drug entry in Korea?
If the patent remains in force, it could delay generic entry until expiry or invalidation, thereby providing commercial exclusivity to the patent holder and influencing pricing and market competition.
5. Can the patent claims in KR20120104446 be challenged or invalidated?
Yes, via invalidation proceedings based on grounds such as lack of novelty, inventive step, or prior art disclosures. The strength of claims against such challenges depends on prior art and claim drafting quality.
Sources
- Korean Intellectual Property Office (KIPO) patent database.
- WIPO patent database for international family data.
- Patent prosecution records and legal status reports.
- Industry reports on South Korea patent filings and pharmaceutical innovation.
- Judicial and administrative decisions related to patent validity and infringement cases.
In conclusion, KR20120104446 epitomizes South Korea's strategic focus on protecting chemical and pharmaceutical innovations. Its scope and claims are designed to offer a robust defensive shield in the competitive biotech landscape, making it a critical asset in the patent portfolio of its owner and influencing regional and possibly global pharmaceutical development trajectories.
